Related references
Note: Only part of the references are listed.Galanin and neuropeptide Y interactions elicit antidepressant activity linked to neuronal precursor cells of the dentate gyrus in the ventral hippocampus
Dasiel O. Borroto-Escuela et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Role of the galanin N-terminal fragment (1-15) in anhedonia: Involvement of the dopaminergic mesolimbic system
Carmelo Millon et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Galanin (1-15)-fluoxetine interaction in the novel object recognition test. Involvement of 5-HT1A receptors in the prefrontal cortex of the rats
Antonio Flores-Burgess et al.
NEUROPHARMACOLOGY (2019)
A Novel Integrative Mechanism in Anxiolytic Behavior Induced by Galanin 2/Neuropeptide Y Y1 Receptor Interactions on Medial Paracapsular Intercalated Amygdala in Rats
Manuel Narvaez et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
The neuropeptides Galanin and Galanin(1-15) in depression-like behaviours
Carmelo Millon et al.
NEUROPEPTIDES (2017)
Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depression
Antonio Flores-Burgess et al.
NEUROPHARMACOLOGY (2017)
Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the dentate gyrus are related with antidepressant-like effects
Manuel Narvaez et al.
BRAIN STRUCTURE & FUNCTION (2016)
Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system
Carmelo Millon et al.
BRAIN STRUCTURE & FUNCTION (2016)
Chronic venlafaxine treatment fails to alter the levels of galanin system transcripts in normal rats
Peter Petschner et al.
NEUROPEPTIDES (2016)
Alterations in the neuropeptide galanin system in major depressive disorder involve levels of transcripts, methylation, and peptide
Swapnali Barde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A Role for Galanin N-Terminal Fragment (1-15) in Anxiety- and Depression-Related Behaviors in Rats
Carmelo Millon et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions
Manuel Narvaez et al.
BRAIN STRUCTURE & FUNCTION (2015)
Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex
Dasiel O. Borroto-Escuela et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
PLASMA GALANIN IS A BIOMARICER FOR SEVERITY OF MAJOR DEPRESSIVE DISORDER
Yong-Jun Wang et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2014)
GAL3 receptor KO mice exhibit an anxiety-like phenotype
Susanne M. Brunner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Brain galanin system genes interact with life stresses in depression-related phenotypes
Gabriella Juhasz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females
Lynn M. Almli et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2013)
Neuropeptide S receptor gene is associated with cortisol responses to social stress in humans
Robert Kumsta et al.
BIOLOGICAL PSYCHOLOGY (2013)
Induction of galanin after chronic sertraline treatment in mouse ventral dentate gyrus
Misa Yamada et al.
BRAIN RESEARCH (2013)
Novel systemically active galanin receptor 2 ligands in depression-like behavior
Indrek Saar et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Non-Monoaminergic Targets for the Development of Antidepressants: Focus on Neuropeptides
Mario Catena-Dell'Osso et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
Novel Galanin Receptor Subtype Specific Ligand in Depression Like Behavior
Indrek Saar et al.
NEUROCHEMICAL RESEARCH (2013)
Neuropeptides in learning and memory
Eva Borbely et al.
NEUROPEPTIDES (2013)
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Viktoria Kormos et al.
NEUROPEPTIDES (2013)
PACAP and the PAC1 Receptor in Post-Traumatic Stress Disorder
Brian G. Dias et al.
NEUROPSYCHOPHARMACOLOGY (2013)
CRF Mediates the Anxiogenic and Anti-Rewarding, But Not the Anorectic Effects of PACAP
Riccardo Dore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
THE ROLE OF GALANIN SYSTEM IN MODULATING DEPRESSION, ANXIETY, AND ADDICTION-LIKE BEHAVIORS AFTER CHRONIC RESTRAINT STRESS
X. Zhao et al.
NEUROSCIENCE (2013)
Identification of a Role for the Ventral Hippocampus in Neuropeptide S-Elicited Anxiolysis
Julien Dine et al.
PLOS ONE (2013)
PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress
Michael L. Lehmann et al.
PSYCHONEUROENDOCRINOLOGY (2013)
A paradoxical association of an oxytocin receptor gene polymorphism: early-life adversity and vulnerability to depression
Robyn J. McQuaid et al.
FRONTIERS IN NEUROSCIENCE (2013)
Neurokinin-1 receptor deletion modulates behavioural and neurochemical alterations in an animal model of depression
M. Roche et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Neuropeptides as Therapeutic Targets in Anxiety Disorders
En-Ju D. Lin
CURRENT PHARMACEUTICAL DESIGN (2012)
Depression as a disease of modernity: Explanations for increasing prevalence
Brandon H. Hidaka
JOURNAL OF AFFECTIVE DISORDERS (2012)
PACAP is an Endogenous Protective Factor-Insights from PACAP-Deficient Mice
D. Reglodi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Neuropeptide Y Y1 Receptor Hippocampal Overexpression Via Viral Vectors Is Associated With Modest Anxiolytic-Like and Proconvulsant Effects in Mice
M. V. Olesen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned
N. R. Wray et al.
MOLECULAR PSYCHIATRY (2012)
Stress-Related Neuropeptides and Addictive Behaviors: Beyond the Usual Suspects
Jesse R. Schank et al.
NEURON (2012)
Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain
Molly L. Rovin et al.
NEUROPEPTIDES (2012)
THE BEHAVIORAL PHENOTYPE OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE-DEFICIENT MICE IN ANXIETY AND DEPRESSION TESTS IS ACCOMPANIED BY BLUNTED c-Fos EXPRESSION IN THE BED NUCLEUS OF THE STRIA TERMINALIS, CENTRAL PROJECTING EDINGER-WESTPHAL NUCLEUS, VENTRAL LATERAL SEPTUM, AND DORSAL RAPHE NUCLEUS
B. Gaszner et al.
NEUROSCIENCE (2012)
VASOPRESSIN V1a AND V1b RECEPTORS: FROM MOLECULES TO PHYSIOLOGICAL SYSTEMS
Taka-aki Koshimizu et al.
PHYSIOLOGICAL REVIEWS (2012)
[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies
C. Ruzza et al.
PEPTIDES (2012)
Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus
Elizabeth I. Flandreau et al.
PSYCHONEUROENDOCRINOLOGY (2012)
Galanin Receptors and Ligands
Kristin E. B. Webling et al.
Frontiers in Endocrinology (2012)
On the existence and function of galanin receptor heteromers in the central nervous system
Kjell Fuxe et al.
Frontiers in Endocrinology (2012)
PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response
Nikolas Stroth et al.
TRENDS IN NEUROENDOCRINOLOGY (2011)
The Role of the PACAP Signaling System in Depression
Albert Pinhasov et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
PACAP is Implicated in the Stress Axes
Hitoshi Hashimoto et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation
L. Regev et al.
MOLECULAR PSYCHIATRY (2011)
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Kerry J. Ressler et al.
NATURE (2011)
Neuropeptide-S (NPS) Receptor Genotype Modulates Basolateral Amygdala Responsiveness to Aversive Stimuli
Udo Dannlowski et al.
NEUROPSYCHOPHARMACOLOGY (2011)
GALANIN RECEPTOR 2 OVEREXPRESSING MICE DISPLAY AN ANTIDEPRESSIVE-LIKE PHENOTYPE: POSSIBLE INVOLVEMENT OF THE SUBICULUM
T. Wardi Le Maitre et al.
NEUROSCIENCE (2011)
Modulation of the CRH system by substance P/NKA in an animal model of depression
Pamela Frisch et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Roles for Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Expression and Signaling in the Bed Nucleus of the Stria Terminalis (BNST) in Mediating the Behavioral Consequences of Chronic Stress
Sayamwong E. Hammack et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice
E. Painsipp et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Pathogenic involvement of neuropeptides in anxiety and depression
Brett Alldredge
NEUROPEPTIDES (2010)
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist
Robert H. Ring et al.
NEUROPHARMACOLOGY (2010)
Gender-Specific Association of Galanin Polymorphisms with HPA-Axis Dysregulation, Symptom Severity, and Antidepressant Treatment Response
Paul G. Unschuld et al.
NEUROPSYCHOPHARMACOLOGY (2010)
STRESS HORMONE SYNTHESIS IN MOUSE HYPOTHALAMUS AND ADRENAL GLAND TRIGGERED BY RESTRAINT IS DEPENDENT ON PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE SIGNALING
N. Stroth et al.
NEUROSCIENCE (2010)
Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder
Ryota Hashimoto et al.
NEUROSCIENCE LETTERS (2010)
Behavioral effects of neuropeptides in rodent models of depression and anxiety
Susan Rotzinger et al.
PEPTIDES (2010)
Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1
Hongyan Zhu et al.
PSYCHONEUROENDOCRINOLOGY (2010)
The effects of stressful stimuli and hypothalamic-pituitary-adrenal axis activation are reversed by the melanin-concentrating hormone 1 receptor antagonist SNAP 94847 in rodents
Daniel G. Smith et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Behavioral phenotyping of Neuropeptide S receptor knockout mice
Dee M. Duangdao et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings
L. Raiteri et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression
Konstantinos A. Paschos et al.
CNS DRUGS (2009)
NEUROPEPTIDES: RELEVANCE IN TREATMENT OF DEPRESSION AND ANXIETY DISORDERS
Vishal Madaan et al.
DRUG NEWS & PERSPECTIVES (2009)
The MCH1 receptor antagonist SNAP 94847 induces sensitivity to dopamine D2/D3 receptor agonists in rats and mice
Douglas A. Marsteller et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone
Hitoshi Hashimoto et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes
E. Keen-Rhinehart et al.
MOLECULAR PSYCHIATRY (2009)
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
D. Vaudry et al.
PHARMACOLOGICAL REVIEWS (2009)
Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): Roles for PACAP in anxiety-like behavior
Sayamwong E. Hammack et al.
PSYCHONEUROENDOCRINOLOGY (2009)
A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder
Adam J. Guastella et al.
PSYCHONEUROENDOCRINOLOGY (2009)
Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior
C. J. Bleickardt et al.
PSYCHOPHARMACOLOGY (2009)
Combined Effects of Exonic Polymorphisms in CRHR1 and AVPR1B Genes in a Case/Control Study for Panic Disorder
Martin E. Keck et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
Vasopressin Does Not Mediate Hypersensitivity of the Hypothalamic Pituitary Adrenal Axis during Chronic Stress
Jun Chen et al.
STRESS, NEUROTRANSMITTERS, AND HORMONES: NEUROENDOCRINE AND GENETIC MECHANISMS (2008)
Substance P in Stress and Anxiety NK-1 Receptor Antagonism Interacts with Key Brain Areas of the Stress Circuitry
Karl Ebner et al.
NEURAL SIGNALING: OPPORTUNITIES FOR NOVEL DIAGNOSTIC APPROACHES AND THERAPIES (2008)
Influence of child abuse on adult depression - Moderation by the corticotropin-releasing hormone receptor gene
Rebekah G. Bradley et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Attachment, aggression and affiliation: The role of oxytocin in female social behavior
Anne Campbell
BIOLOGICAL PSYCHOLOGY (2008)
Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology
K. Fuxe et al.
BRAIN RESEARCH REVIEWS (2008)
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice
A. Rizzi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Galanin, galanin receptor subtypes and depression-like behaviour
E. Kuteeva et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Oxytocin levels in social anxiety disorder
Elizabeth A. Hoge et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
Control of the hypothalamo-pituitary-adrenal axis in the neonatal period: Adrenocorticotropin and corticosterone stress responses dissociate in vasopressin-deficient Brattleboro rats
Dora Zelena et al.
ENDOCRINOLOGY (2008)
Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity
Gina L. Forster et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
The vasopressin system - From antidiuresis to psychopathology
Elisabeth Frank et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats
Mark J. Millan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Brain oxytocin: A key regulator of emotional and social behaviours in both females and males
I. D. Neumann
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia
Tammy J. Sajdyk et al.
JOURNAL OF NEUROSCIENCE (2008)
The Role of Neuropeptide Y in the Expression and Extinction of Fear-Potentiated Startle
Alisa R. Gutman et al.
JOURNAL OF NEUROSCIENCE (2008)
Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder
C. S. de Kloet et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior
A. Lu et al.
MOLECULAR PSYCHIATRY (2008)
Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances
S-S Wang et al.
MOLECULAR PSYCHIATRY (2008)
Genetic variation in human NPY expression affects stress response and emotion
Zhifeng Zhou et al.
NATURE (2008)
Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests
Xiaoying Lu et al.
NEUROPEPTIDES (2008)
Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level
Eugenia Kuteeva et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Corticosterone release in oxytocin gene deletion mice following exposure to psychogenic versus non-psychogenic stress
Janet A. Amico et al.
NEUROSCIENCE LETTERS (2008)
Anxiolytic-like effect of neuropeptide S in the rat defensive burying
Giovanni Vitale et al.
PEPTIDES (2008)
Vasopressin: Behavioral roles of an original neuropeptide
Heather K. Caldwell et al.
PROGRESS IN NEUROBIOLOGY (2008)
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders
Sarah K. Leonard et al.
PSYCHOPHARMACOLOGY (2008)
Evidence of Dysregulated Peripheral Oxytocin Release Among Depressed Women
Jill M. Cyranowski et al.
PSYCHOSOMATIC MEDICINE (2008)
Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin
C. Becker et al.
MOLECULAR PSYCHIATRY (2008)
From MIF-1 to endomorphin: The Tyr-MIF-1 family of peptides
Weihonq Pan et al.
PEPTIDES (2007)
Nicotine treatment regulates neuropeptide S system expression in the rat brain
Ricardo Lage et al.
NEUROTOXICOLOGY (2007)
Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon
S. Johannes R. Rajarao et al.
NEUROPEPTIDES (2007)
Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder
Naoe Okamura et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities.: Do neuropeptides play a role?
Aleksander A. Mathe et al.
PHYSIOLOGY & BEHAVIOR (2007)
The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors:: Possible relevance for affective disorders
Sven Ove Ogren et al.
PHYSIOLOGY & BEHAVIOR (2007)
Plasma oxytocin levels and anxiety in patients with major depression
G. Scantamburlo et al.
PSYCHONEUROENDOCRINOLOGY (2007)
Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice
Jakub Fichna et al.
NEUROPSYCHOPHARMACOLOGY (2007)
A novel DISC1-interacting partner DISC1-binding zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth
T. Hattori et al.
MOLECULAR PSYCHIATRY (2007)
Assessment of antidepressant and anxiolytic properties of NK1 antagonists and Substance P in Wistar Kyoto rats
O. Malkesman et al.
PHYSIOLOGY & BEHAVIOR (2007)
Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice
Nobuaki Egashira et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders
Zhongchun Liu et al.
NEUROSCIENCE LETTERS (2007)
Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression
R. A. Hodgson et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze
Kathleen R. Bailey et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain
Yan-Ling Xu et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat
Eugenia Kuteeva et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor
Hisahito Ishida et al.
HIPPOCAMPUS (2007)
Caffeine treatment regulates neuropeptide S system expression in the rat brain
Ricardo Lage et al.
NEUROSCIENCE LETTERS (2006)
Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: A preliminary report
Gerben Meynen et al.
BIOLOGICAL PSYCHIATRY (2006)
Differential disinhibition of the neonatal hypothalamic-pituitary-adrenal axis in brain-specific CRH receptor 1-knockout mice
M. V. Schmidt et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder
Stuart A. Montgomery et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Antidepressant-like effects of the corticotropin-releasing factor I receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72s schedule in the rat
Caroline Louis et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats
Sameer N. Goyal et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
The role of substance P in stress and anxiety responses
K. Ebner et al.
AMINO ACIDS (2006)
A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests
Alasdair M. Barr et al.
NEUROSCIENCE LETTERS (2006)
Association of corticotropin-releasing hormone receptorl gene SNP and haplotype with major depression
Zhongchun Liu et al.
NEUROSCIENCE LETTERS (2006)
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake
Kirsty L. Smith et al.
ENDOCRINOLOGY (2006)
CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder
Cailan Hou et al.
BRAIN RESEARCH (2006)
Plasma neuropeptide y concentrations in combat exposed veterans: Relationship to trauma exposure, recovery from PTSD, and coping
R Yehuda et al.
BIOLOGICAL PSYCHIATRY (2006)
Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications
RH Ring et al.
PSYCHOPHARMACOLOGY (2006)
Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects
Z Merali et al.
BIOLOGICAL PSYCHIATRY (2006)
Depression with above-normal plasma vasopressin: Validation by relations with family history of depression and mixed anxiety and retardation
JG Goekoop et al.
PSYCHIATRY RESEARCH (2006)
Lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder
M Keller et al.
BIOLOGICAL PSYCHIATRY (2006)
Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor
A Fisher et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Genetic inactivation of melanin-concentrating hormone receptor subtype 1 (MCHR1) in mice exerts anxiolytic-like behavioral effects
M Roy et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: A multicenter study
H Kunugi et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Melanin-concentrating hormone MCH1 receptor antagonists - A potential new approach to the treatment of depression and anxiety disorders
Toshiharu Shimazaki et al.
CNS DRUGS (2006)
Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls
K Held et al.
PSYCHONEUROENDOCRINOLOGY (2006)
Emotional behavior in aged neuropeptide Y (NPY)Y-2 knockout mice
C Carvajal et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2006)
Comparison of systemic exposure to nemifitide following two methods of subcutaneous administration to healthy volunteers
G Nicolau et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2005)
Cholecystokinin and endogenous opioid peptides: Interactive influence on pain, cognition, and emotion
ALO Hebb et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299
CJ Swanson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram
G Nikisch et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin
TG Dinan et al.
JOURNAL OF ANATOMY (2005)
Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder
K Isogawa et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2005)
The V1a vasopressin receptor is necessary and sufficient for normal social recognition: A gene replacement study
IF Bielsky et al.
NEURON (2005)
The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders
DE Grigoriadis
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene
A Agarwal et al.
MOLECULAR BRAIN RESEARCH (2005)
Substance P in serum and cerebrospinal fluid of depressed patients: No effect of antidepressant treatment
M Deuschle et al.
PSYCHIATRY RESEARCH (2005)
Behavioural characterisation of transgenic mice overexpressing galanin under the PDGF-B promoter
E Kuteeva et al.
NEUROPEPTIDES (2005)
The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus Accumbens to modulate feeding Behavior and forced-swim performance
D Georgescu et al.
JOURNAL OF NEUROSCIENCE (2005)
Neuropeptide expression in rats exposed to chronic mild stresses
V Sergeyev et al.
PSYCHOPHARMACOLOGY (2005)
Galanin and its receptors in neurological disorders
L Lundstrom et al.
NEUROMOLECULAR MEDICINE (2005)
A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus
XY Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat
LJ Dableh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats
H Wang et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Non-peptide vasopress in V-1b receptor antagonists as potential drugs for the treatment of stress-related disorders
G Griebel et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Substance P in the medial amygdala: Emotional stress-sensitive release and modulation of anxiety-related behavior in rats
K Ebner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice
IF Bielsky et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Dysregulation in the suicide brain:: mRNA expression of corticotropin-releasing hormone receptors and GABAA receptorsubunits in frontal cortical brain region
Z Merali et al.
JOURNAL OF NEUROSCIENCE (2004)
Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression
MS Kramer et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression
DH Overstreet et al.
PSYCHOPHARMACOLOGY (2004)
Serum levels of substance P and response to antidepressant pharmacotherapy
K Lieb et al.
PHARMACOPSYCHIATRY (2004)
Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects
YL Xu et al.
NEURON (2004)
The NPY system in stress, anxiety and depression
M Heilig
NEUROPEPTIDES (2004)
5-HT1A receptors, gene repression, and depression: Guilt by association
PR Albert et al.
NEUROSCIENTIST (2004)
The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal aids activity under both stress and resting conditions
A Tanoue et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation
S Volpi et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2004)
Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors
A Tschenett et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Elevated concentrations of CRF in the locus coeruleus of depressed subjects
G Bissette et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze
A Holmes et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Galanin attenuates basal and antidepressant drug-induced increase of extracellular serotonin and noradrenaline levels in the rat hippocampus
T Yoshitake et al.
NEUROSCIENCE LETTERS (2003)
Effect of direct injection of melanin-concentrating hormone into the paraventricular nucleus: Further evidence for a stimulatory role in the adrenal axis via SLC-1
AR Kennedy et al.
JOURNAL OF NEUROENDOCRINOLOGY (2003)
Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model
ME Keck et al.
NEUROPSYCHOPHARMACOLOGY (2003)
The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats
ME Keck et al.
PHARMACOPSYCHIATRY (2003)
The Vasopressin V-1b Receptor as a Therapeutic Target in Stress-related Disorders
Guy Griebel et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2003)
Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects
HE Kunzel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2003)
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
A Holmes et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice
M Nomura et al.
JOURNAL OF NEUROENDOCRINOLOGY (2003)
Pituitary adenylate cyclase-activating peptide in the rat central nervous system: An immunohistochemical and in situ hybridization study
J Hannibal
JOURNAL OF COMPARATIVE NEUROLOGY (2002)
Neuropeptide Y (NPY) and depression: From animal studies to the human condition
JP Redrobe et al.
LIFE SCIENCES (2002)
Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment
SC Stout et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Neuropeptides involved in the pathophysiology of schizophrenia and major depression
David De Wied et al.
NEUROTOXICITY RESEARCH (2002)
Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs
NMJ Rupniak et al.
BEHAVIOURAL PHARMACOLOGY (2001)
Schizophrenia and affective disorders - Cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: Clinical and P300 findings in a family
DHR Blackwood et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Evolution of vertebrate neuropeptides
S Holmgren et al.
BRAIN RESEARCH BULLETIN (2001)
Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression
JN Zhou et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
The Oxytocin Receptor System: Structure, function, and regulation
G Gimpl et al.
PHYSIOLOGICAL REVIEWS (2001)
Stress, hypercortisolism and corticosteroid receptors in depression: implicatons for therapy
F Holsboer
JOURNAL OF AFFECTIVE DISORDERS (2001)
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression
A Thorsell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats
M Papp et al.
BEHAVIOURAL BRAIN RESEARCH (2000)
Behavioral characterization of neuropeptide Y knockout mice
AW Bannon et al.
BRAIN RESEARCH (2000)
Disruption of two novel genes by a translocation co-segregating with schizophrenia
JK Millar et al.
HUMAN MOLECULAR GENETICS (2000)
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
TL Bale et al.
NATURE GENETICS (2000)
The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat
GJ Hervieu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Galanin-(1-16) modulates 5-HTIA receptors in the ventral limbic cortex of the rat
Z Díaz-Cabiale et al.
NEUROREPORT (2000)
Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze
KT Britton et al.
PEPTIDES (2000)
Share Paper
